Valuation: InMode Ltd.

Market Cap 889M 781M 729M 669M 1.25B 85.17B 1.28B 8.65B 3.38B 42.15B 3.34B 3.27B 146B P/E 2026 *
13.4x
P/E 2027 * 12.1x
Enterprise Value 889M 781M 729M 669M 1.25B 85.17B 1.28B 8.65B 3.38B 42.15B 3.34B 3.27B 146B EV / Sales 2026 *
2.4x
EV / Sales 2027 * 2.35x
Free-Float
60.55%
Yield 2026 *
-
Yield 2027 * -
1 day-2.10%
1 week-0.20%
Current month+3.76%
1 month+2.92%
3 months+8.67%
6 months-5.31%
Current year+3.27%
1 week 14.98
Extreme 14.98
15.6
1 month 14.4
Extreme 14.4
15.67
Current year 12.72
Extreme 12.72
16.67
1 year 12.72
Extreme 12.72
16.74
3 years 12.72
Extreme 12.72
44.41
5 years 12.72
Extreme 12.72
99.27
10 years 6.53
Extreme 6.53
99.27
Manager TitleAgeSince
Chief Tech/Sci/R&D Officer 59 2008-01-01
Chief Executive Officer 73 2008-01-01
Director of Finance/CFO 41 2026-05-18
Director TitleAgeSince
Chairman 73 2008-01-01
Director/Board Member 59 2019-08-06
Chairman 67 2026-05-04
Date Insider Type Main position Quantity % Market Cap.
5/19/26 Other

Chairman

0 0%
5/19/26 Other

Chief Financial Officer

26,733 0.0422%
3/18/26 Other

Chairman

10,000 0.0158%
Change 5-day change 1-year change 3-year change Capi.($)
-2.00%-0.20%+6.01%-64.65% 889M
-0.54%+8.75%+18.74%+4.35% 214B
-0.48%+10.43%-4.37%-22.44% 140B
-2.05%+4.01%-28.69%+9.23% 128B
+0.53%+7.12%-56.77%-11.22% 68.46B
+2.38%+1.04%+5.93%+3.87% 48.18B
+4.51%+8.59%-22.65%-28.93% 45.56B
-0.32%+4.90%+16.82%+14.97% 39.69B
-1.03%+2.38%+25.22%+37.45% 37.69B
+2.39%+10.44%-23.28%-4.18% 30.14B
Average +0.36%+4.14%-6.30%-6.16% 75.26B
Weighted average by Cap. -0.02%+5.29%-5.28%-1.47%

Financials

2026 *2027 *
Net sales 370M 325M 304M 279M 522M 35.46B 535M 3.6B 1.41B 17.55B 1.39B 1.36B 60.67B 379M 333M 311M 285M 534M 36.3B 547M 3.69B 1.44B 17.96B 1.42B 1.39B 62.1B
Net income 72.86M 64.02M 59.76M 54.84M 103M 6.98B 105M 709M 277M 3.45B 274M 268M 11.94B 78.41M 68.9M 64.31M 59.02M 110M 7.51B 113M 763M 298M 3.72B 294M 288M 12.85B
Net Debt - -
Logo InMode Ltd.
Inmode Ltd is an Israel-based global provider of energy-based, minimally-invasive surgical medical treatment solutions. Company's products and solutions are primarily designed to address three energy-based treatment categories comprised of: face and body contouring; medical aesthetics; and women’s health. The Company have developed and commercialized products utilizing medically-accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing adipose tissue remodeling. It's RF energy-based proprietary technologies - Radio Frequency Assisted Lipolysis (RFAL), Deep Subdermal Fractional RF, Simultaneous Fat Destruction and Skin Tightening and Deep Heating Collagen Remodeling for skin and human natural openings- represent a paradigm shift in the minimally-invasive aesthetic solutions market. These technologies are used by physicians to remodel subdermal adipose, or fatty tissue in a variety of procedures.
Employees
660
Date Price Change Volume
26-07-29 US$15.17 -1.97% 615,136
26-07-28 US$15.47 +0.59% 586,145
26-07-27 US$15.38 +1.38% 688,606
26-07-24 US$15.17 +0.53% 419,196
26-07-23 US$15.09 -0.72% 536,870
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
15.47USD
Average target price
15.33USD
Spread / Average Target
-0.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INMD Stock